Search Results
72 Results for 'Drug Delivery'
PAGE 2 OF 3
Technology
Kras Conditional Knockout Allele
Differentiation of normal stem cells into the correct cell lineage is a tightly controlled process that involves cell-cell and cell-extracellular matrix interactions as well as signaling through cellu...
Learn More
Learn More
Jing Zhang | P210181US01
Technology
Universal Multi-Functional GSH-Responsive Silica Nanoparticles For Delivery Of Biomolecules Into Cells
The present technology provides a nanoparticle comprising: a silica network comprising crosslinked polysiloxanes, wherein the crosslinks between polysiloxanes comprise disulfide linkages, the polysilo...
Learn More
Learn More
Shaoqin Gong, Yuyuan Wang | P200169WO01
Technology
Reagents & Methods for Using Human Embryonic Stem Cells to Evaluate Developmental Toxicity for Pharmaceutical Compounds & Other Chemicals
The invention provides biomarker profiles of cellular metabolites and methods for screening chemical compounds including pharmaceutical agents, lead and candidate drug compounds and other chemicals us...
Learn More
Learn More
Gabriela Cezar | P06130US
Technology
Microbial Glycans As A Target Of Human Intelectin
The present disclosure provides for methods of diagnosing and treating bacterial infections. Human Intelectin 1 (hIntL-1) has been shown to bind selectively to glycan components on bacteria including ...
Learn More
Learn More
Laura Kiessling, Darryl Wesener, Kittikhun Wangkanont | P150027US02
Technology
Osmotic Enhancement Of Drug/Therapeutic Delivery To The Brain Following Infusion Or Injection Into The Cerebrospinal Fluid
A method of enhancing therapeutic/drug transport to the perivascular space of the brain of a patient is disclosed. In one embodiment, the method comprises the step of introducing a therapeutic/drug an...
Learn More
Learn More
Robert Thorne, Daniel Wolak, Michelle Pizzo | P160077US02
Technology
Unimolecular Nanoparticles For Efficient Delivery Of Therapeutic Rna
A unimolecular nanoparticle, a composition thereof, and methods of use thereof that includes 1) a dendritic polymer having a molecular weight of about 500-120,000 Da and terminating in hydroxyl, amino...
Learn More
Learn More
Shaoqin Gong, Guojun Chen | P170119US02
Technology
Unimolecular Nanoparticles For Efficient Delivery Of Therapeutic Cationic Peptides
Provided herein are peptides comprising an amino acid sequence having at least about 85% sequence identity to RYRPRAPIIAVT (SEQ ID NO: 1). These cationic peptides inhibit PKM2 methylation and may be u...
Learn More
Learn More
Shaoqin Gong, Wei Xu, Yuyuan Wang, Fabao Liu | P170128US02
Technology
Methods And Culture Substrates For Controlled Induction Of Biomimetic Neural Tissues Comprising Singular Rosette Structures
Described herein are methods, compositions, and kits for directed differentiation of human pluripotent stem cells, neuromesodermal progenitors, and neural stem cells into biomimetic neural tissues com...
Learn More
Learn More
Randolph Ashton, Gavin Knight | P170180US02
Technology
An Ionic Liquid-Based Nanoemulsion Formulation For The Efficient Delivery Of Hydrophobic Therapeutic Agents
The present invention discloses an ionic liquid composition comprising an at least partially hydrophobic ionic liquid, wherein the at least partially hydrophobic ionic liquid comprises a dication comp...
Learn More
Learn More
Sandro Mecozzi, Moira Esson | P180283US02
Technology
Human Pluripotent Stem Cell-Derived Brain Organoids For Cancer Modeling And Drug Screening
The present invention relates to substantially planar vascularized brain cancer organoid and methods of using such vascularized brain cancer organoids in anti-cancer drug discovery screen. In particul...
Learn More
Learn More
William Murphy, Elizabeth Aisenbrey, Elizabeth Torr, Victoria Harms, Gaurav Kaushik | P190185US02
Technology
Mineral Coated Microparticles For Co-Delivery Of Anti-Inflammatory Molecules With Nucleic Acids To Improve Gene Delivery Outcomes
Disclosed are compositions and methods for the co-delivery of ribonucleic acids and interferon binding proteins. Compositions include mineral coated microparticles having a mineral layer, a ribonuclei...
Learn More
Learn More
William Murphy, Andrew Khalil, Xiaohua Yu | P170170US02
Technology
Mineral Coated Microparticles For Gene Delivery In Chronic Wound Therapy
Disclosed are formulations for providing a therapeutic bioactive polypeptide to injured tissue. Formulations include mineral coated microparticles wherein a polynucleotide is adsorbed to the mineral l...
Learn More
Learn More
William Murphy, Andrew Khalil, Xiaohua Yu | P170173US02
Technology
Vector For Gene Silencing And Replacement And Methods Of Use Thereof
An expression cassette for gene silencing and replacement, including, in operable communication, a promoter, an expression attenuator, a nucleotide sequence encoding a gene for a replacement target pr...
Learn More
Learn More
Erik Dent, Matthew Millette | P180170US02
Technology
Nanocapsule Delivery System For Ribonucleoproteins
With the explosion of interest in using the CRISPR/Cas9 system for gene editing, there is a strong focus on developing tools for delivering the CRISPR machinery safely and efficiently into cells. Exis...
Learn More
Learn More
Shaoqin Gong, Krishanu Saha, Guojun Chen, Amr Abdeen, Yuyuan Wang, Ruosen Xie | P170376US02
Technology
Polyplex Delivery System For Proteins, Nucleic Acids And Protein/Nucleic Acid Complexes
With an increasing interest in using the CRISPR/Cas9 system for gene editing, there comes a strong need to develop tools for delivering the CRISPR machinery safely and efficiently into cells. Existing...
Learn More
Learn More
Shaoqin Gong, Yuyuan Wang, Krishanu Saha, Amr Abdeen | P180158US02
Technology
Engineered Probiotics as Systemic Therapeutic Delivery Platform
Polypeptides, such as enzymes, antibodies, hormones and cytokines, are useful therapeutic agents. However, routes for systemically introducing such polypeptides to a subject are limited. Oral administ...
Learn More
Learn More
Jan Peter Van Pijkeren, Alan Attie, Mark Keller, Jeehwan Oh | P160109US02
Technology
S1mplex: A New Tool for Precision Gene Editing
New tools for human gene editing are rapidly advancing all sectors of biomedicine from basic biology to somatic gene therapy in the clinic. Precise editing of DNA sequences in the human genome can be ...
Learn More
Learn More
Krishanu Saha, Jared Carlson-Stevermer, Amr Abdeen, Lucille Kohlenberg | P170309US02
Technology
An Injectable Nanovehicle for a Cancer Treatment Combination of Paclitaxel, Rapamycin and 17-AAG
Two-drug combinations of paclitaxel and rapamycin (an mTOR inhibitor) as well as paclitaxel and 17-AAG (an enhanced version of geldanamycin and Hsp90 inhibitor) have progressed into human clinical tri...
Learn More
Learn More
Glen Kwon | P090383US03
Technology
Reagents for Bioreversible Protein Esterification
Chemoselective transformations are of key importance in modern chemical biology. Protein esterification can, for example, be employed for labeling, enhanced cellular uptake and other useful protein mo...
Learn More
Learn More
Ronald Raines, Kalie Mix | P150262US03
Technology
Enhanced Drug Delivery Across the Blood-Brain Barrier: pH-Dependent Antibodies Targeting the Transferrin Receptor
Drug delivery to the brain is hampered by the presence of the blood-brain barrier (BBB), which excludes more than 98 percent of small molecule pharmaceuticals and nearly 100 percent of all protein and...
Learn More
Learn More
Eric Shusta, Benjamin Tillotson | P150370US02
Technology
Phage-Cured Lactobacillus Strains for Therapeutic Delivery
In addition to key roles in food and biofuel production, probiotic strains of lactic acid bacteria are being exploited in medicine as therapeutic delivery vehicles. One obstacle is that bacteriophages...
Learn More
Learn More
Jan Peter Van Pijkeren, Jeehwan Oh | P170020US01
Technology
Bioreversible Boronates Improve Drug Delivery
The utility of many biologic drugs is limited by inefficient delivery into cells. Strategies to overcome this limitation have included enhancing the attraction between positively charged drug agents a...
Learn More
Learn More
Ronald Raines, Thomas Smith | P150009US02
Technology
Enhancing Cell Penetration to Improve Drug Delivery
The utility of many biologic drugs is limited by inefficient cellular delivery. There is a particular need for methods and reagents that facilitate delivery of peptides and proteins into the interior ...
Learn More
Learn More
Ronald Raines, Kristen Andersen | P150031US02
Technology
Lipid-Free, Stabilized Emulsions for Delivering Anesthesia and Other Hydrophobic Drugs
Emulsions containing soybean oil have been used intravenously for more than 40 years. Recently they have been employed in the delivery of certain hydrophobic drugs such as anti-inflammatory agents and...
Learn More
Learn More
Sandro Mecozzi, Robert Pearce, William Tucker | P140337US02
Technology
Lipid-Free Emulsions for Delivering Anesthesia, Other Hydrophobic Drugs
Emulsions containing soybean oil have been used intravenously for more than 40 years. Recently they have been employed in the delivery of certain hydrophobic drugs such as anti-inflammatory agents and...
Learn More
Learn More
Sandro Mecozzi, Robert Pearce | P140235US02